Table 1.

CMV and EBV serological status of the subcohort

Clinical features	Young (n = 12)	Older (n =9 )	LLI (n = 6)
Age (years)
Mean ± s.d.	28.69 ± 3.47	82.2 ± 2.60	99.55 ± 5.27
Range	25‐34	79‐88	93‐111
Gender
Female	8 (66.6%)	4 (44.4%)	3 (50%)
Male	4 (33.3%)	5 (55.5%)	3 (50%)
CMV serological status
CMV+ (n, %)	2 (16.6%; 1 F, 1 M)	9 (100%; 4 F, 5 M)	6 (100%, 3 F, 3 M)
Anti‐CMV IgG titre (U/ml)	103–160	44–177	160–>180
EBV serological status
EBV+ (n, %)	12 (100%; 8 F, 4 M)	9 (100%; 4 F, 5 M)	6 (100%, 3 F, 3 M)
Anti‐EBV IgG titre (U/ml)
Range	25.4–>600	17.8–>600	20.48–>600

Abbreviations: CMV, cytomegalovirus; EBV, Epstein–Barr virus; F, females; LLIs, long‐lived individuals; M, males; n, total number; s.d., standard deviation; U/mL, units per millilitre.